Pulmonary hypertension (PH) is a general term used to describe high blood pressure in the lungs from any cause. Pulmonary arterial hypertension (PAH) is a progressive, and fatal disease that causes the walls of the pulmonary arteries to tighten and stiffen. One of the major characteristics of PAH is the hyperproliferation and resistance to apoptosis of vascular cells, which trigger excessive pulmonary vascular remodeling and vasoconstriction. The death-associated protein DAP-kinase (DAPK) is a tumor suppressor and Ser/Thr protein kinase, which was previously shown to regulate the hypoxia inducible factor (HIF)-1
- Seidel, L. M.
- Thudium, J.
- Smith, C.
- Sapehia, V.
- Sommer, N.
- Wujak, M.
- Weissmann, N.
- Seeger, W.
- Schermuly, R. T.
- Novoyatleva, T.
Keywords
- *Death-Associated Protein Kinases/metabolism/genetics
- Humans
- *Cell Proliferation
- *Pulmonary Artery/metabolism/pathology
- *Myocytes, Smooth Muscle/metabolism/pathology
- *Hypoxia-Inducible Factor 1, alpha Subunit/metabolism
- Muscle, Smooth, Vascular/metabolism/pathology
- Hypertension, Pulmonary/metabolism/pathology
- Basic Helix-Loop-Helix Transcription Factors/metabolism
- Animals
- Pulmonary Arterial Hypertension/metabolism/pathology
- Cell Hypoxia
- Cells, Cultured
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase/metabolism
- Glycolysis
- Oxidative Phosphorylation
- Dapk1
- Hif
- Metabolic shift
- Mitochondrial respiration
- Proliferation
- Pulmonary artery smooth muscle cells